D.C. Drug Pricing Law Dies, Again

Law360, New York (October 30, 2007, 12:00 AM EDT) -- On Tuesday, the U.S. Court of Appeals for the Federal Circuit hammered what may be the final nail into the coffin of a District of Columbia law that would have regulated the price of patented drugs in the U.S. capital.

Thirteen judges of the U.S. Court of Appeals for the Federal Circuit — a majority of that circuit court's jurists — refused to rehear as a full court an appeal of an August decision by a three-judge panel of the Federal Circuit invalidating the ordinance....
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.